Two antibodies synergize in triple whammy to pediatric cancers, study finds

STANFORD MEDICINE - January 13, 2022

Robbie Majzner, MD, assistant professor of pediatrics and senior study author: “Anti-GD2 alone did almost nothing in mice, and anti-CD47 didn’t really do anything either, but when we put them together, the mice with neuroblastoma were unexpectedly cured. We just thought this was great and worth exploring further. " Read Article >>

6 views0 comments